These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10976942)

  • 1. Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion.
    Kimelberg HK; Feustel PJ; Jin Y; Paquette J; Boulos A; Keller RW; Tranmer BI
    Neuroreport; 2000 Aug; 11(12):2675-9. PubMed ID: 10976942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat.
    Osuka K; Feustel PJ; Mongin AA; Tranmer BI; Kimelberg HK
    J Neurochem; 2001 Mar; 76(6):1842-50. PubMed ID: 11259502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia.
    Zhang F; White JG; Iadecola C
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):217-26. PubMed ID: 8113318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Ichiki C; Yatsugi S; Shimizu-Sasamata M; Yamaguchi T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):586-91. PubMed ID: 9840429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective activity of tamoxifen in permanent focal ischemia.
    Kimelberg HK; Jin Y; Charniga C; Feustel PJ
    J Neurosurg; 2003 Jul; 99(1):138-42. PubMed ID: 12854756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-alpha acting at the epidermal growth factor receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats.
    Justicia C; Planas AM
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):128-32. PubMed ID: 10027766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and histological neuroprotection by tamoxifen after reversible focal cerebral ischemia.
    Zhang Y; Jin Y; Behr MJ; Feustel PJ; Morrison JP; Kimelberg HK
    Exp Neurol; 2005 Nov; 196(1):41-6. PubMed ID: 16054626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
    Zhang Y; Feustel PJ; Kimelberg HK
    Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
    Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat.
    Tanaka K; Ito D; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
    Brain Res; 2002 Jan; 924(1):98-108. PubMed ID: 11744000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra.
    Zhang Y; Zhang H; Feustel PJ; Kimelberg HK
    Exp Neurol; 2008 Apr; 210(2):514-20. PubMed ID: 18206872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra.
    Feustel PJ; Jin Y; Kimelberg HK
    Stroke; 2004 May; 35(5):1164-8. PubMed ID: 15017010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain.
    Di X; Bullock R; Watson J; Fatouros P; Chenard B; White F; Corwin F
    Stroke; 1997 Nov; 28(11):2244-51. PubMed ID: 9368572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
    Woitzik J; Weinzierl N; Schilling L
    Neurol Res; 2005 Jul; 27(5):509-15. PubMed ID: 15978177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mild hyperthermia on the ischemic infarct volume after middle cerebral artery occlusion in the rat.
    Chen H; Chopp M; Welch KM
    Neurology; 1991 Jul; 41(7):1133-5. PubMed ID: 2067642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats.
    Henninger N; Küppers-Tiedt L; Sicard KM; Günther A; Schneider D; Schwab S
    Exp Neurol; 2006 Oct; 201(2):316-23. PubMed ID: 16814772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroprusside improves blood flow and reduces brain damage after focal ischemia.
    Zhang F; Iadecola C
    Neuroreport; 1993 May; 4(5):559-62. PubMed ID: 8513138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tromethamine (THAM) on infarct volume following permanent middle cerebral artery occlusion in rats.
    Kiening KL; Schneider GH; Unterberg AW; Lanksch WR
    Acta Neurochir Suppl; 1997; 70():188-90. PubMed ID: 9416318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.